Posts by Sandra Ansanay-Alex
Micronarc Prize x PX Group
Apply before 31 August 2026 for the Micronarc Prize x PX Group and try to get CHF 5,000 and a booth at one of Micronarc’s events This annual award recognizes subcontractors in French-speaking Switzerland active in the field of micro- and nanotechnologies—that is, companies that contribute to their clients’ success through technological, business, or service…
Read MoreVenture Technology Connect
Apply for Venture Technology Connect and go to Verbier next November to pitch you project to a selected audience of investors Swiss start-ups are seeking for capital to fuel their growth. And investors want to invest their money intelligently, according to their values and preferences. Venture Technology Connect is coming to the Verbier region for…
Read MoreMission BioCapital Platinum Programme
Apply before 15 May 2026 for next Mission BioCapital Platinum Programme, designed to help early-stage biotech projects Mission BioCapital (MBC), in partnership with sponsors AbbVie, Ono Venture Investment (OVI), Toronto Innovation Acceleration Partners (TIAP), Connecticut Innovations, Alloy Therapeutics, HitGen, CCRM, Goodwin, Norton Rose Fulbright, and van den Boom & Associates announced today that applications are…
Read MoreEPFL Innogrants
Five EPFL-based life sciences startups, Alpion CryoSolutions, Eleum, Feedback Intuitive, MOLECL, and NourishAI are the latest recipients of the EPFL Startup Launchpad Innogrant and Innogrant for biotherapeuthics. Each team has secured CHF 100,000 to accelerate the development of their technology. Alpion CryoSolutions Cryo-electron microscopy has transformed biology by allowing researchers to see proteins in extraordinary detail. However, existing…
Read MoreAC Immune and Eli Lilly Sign New Agreement Worth CHF 10 Million
Eli Lilly has handed Vaud-based AC Immune (Switzerland) 10 million Swiss francs ($12.5 million) to expand their Alzheimer’s disease collaboration as a candidate moves closer to the clinic. The U.S. pharma first tapped up AC Immune in a 2018 deal that included an $81 million upfront fee. That pact, which came with up to 1.7 billion francs ($2.1 billion)…
Read MoreTerapet Launches FLASHVIVO to Enable Real-Time Verification in FLASH Therapy
Gevena-based start-up and CERN spinoff Terapet SA has announced the launch of FLASHVIVO, a new collaborative research and development project designed to tackle one of the most critical challenges facing the clinical adoption of FLASH radiotherapy: the lack of real-time, in vivo treatment verification under ultra-high dose rate conditions. FLASH radiotherapy has emerged as a…
Read MoreSMART Challenge
The SMART Challenge 2026 kicks off on 21 April 2026 —and it needs concrete, innovative ideas to make physical activity more accessible, more appealing, and above all… easier to incorporate into daily life. Are you an entrepreneur, a student, a healthcare professional, or simply someone with an impactful idea that needs to be tested in…
Read MoreFondation des HUG – Call For Projects
Thanks to the generous support of a private Geneva-based foundation, the Fondation privée des HUG is launching five new calls for projects in 2026, with a total funding envelope of CHF 10 million. This major initiative aims to support projects led by teams from the Geneva University Hospitals (HUG) and the Faculty of Medicine at…
Read MoreOculis Announces European Medicines Agency PRIME Designation for Privosegtor
Oculis Holding AG, based in canton of Vaud and Zug, has received a significant regulatory boost for its neuroprotective candidate Privosegtor, with the European Medicines Agency (EMA) granting the therapy Priority Medicines (PRIME) designation for the treatment of optic neuritis (ON). Optic neuritis is a rare and sight-threatening condition that can occur as a relapse…
Read MoreStarting up in Women’s Health
Starting up in Women’s Health is taking place on 23 April 2026 at Sitem-Insel in Bern Women’s health is entering a new era of innovation—driven by advances in gender medicine, digital technologies, and entrepreneurial potential. This seminar brings together experts from research, clinical practice, digital health, and venture capital to explore how scientific insights can be…
Read More